# A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria

> **NCT04159701** · PHASE2 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 52 (actual)

## Conditions studied

- Chronic Spontaneous Urticaria

## Interventions

- **DRUG:** LY3454738
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04159701
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-15
- **Primary completion:** 2021-02-24
- **Final completion:** 2021-02-24
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** The study was terminated for lack of efficacy after an interim analysis was performed
- **Last updated:** 2022-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04159701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04159701, "A Study of LY3454738 in Adults With Chronic Spontaneous Urticaria". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04159701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*